Kitty Yale

Kitty Yale serves as EVP and Chief Development Officer at Akero Therapeutics. Akero Therapeutics operates in the research sector with approximately 70.0 employees. The company is headquartered in San Francisco, California.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Akero Therapeutics.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

NetSuite Mimecast New Relic Mobile Friendly Google Maps reCAPTCHA Google Tag Manager Akamai RUM Vimeo WordPress.org Gravity Forms Google Font API Google Analytics Remote AI

biotechnology: pharmaceutical preparations health care biotechnology research metabolic diseases efruxifermin mash biopharmaceutical clinical trials therapeutic areas investigational drug research programs expanded access translational medicine drug development liver disease metabolic dysfunction fc-fgf21 fusion protein clinical development biotechnology unmet medical need novel therapies patient outcomes clinical stage pipeline biotechnology company cholesterol management liver health drug commercialization investor relations medical affairs regulatory affairs therapeutic innovation clinical research patient-centric personalized medicine fda approved breakthrough therapy safety & efficacy biomarkers scientific expertise collaborative culture science-driven healthcare conferences stock information corporate governance quality assurance strategic partnerships funding investments market potential commercial strategy healthcare investment clinical research operations physician-scientist clinical-stage biotechnology innovative treatments metabolic dysfunction-associated steatohepatitis non-alcoholic steatohepatitis fgf21 fusion protein liver fibrosis chronic liver disease transformative therapies high unmet medical needs metabolic disorders collaboration scientific innovation financial stability biopharmaceutical sector healthcare providers obesity type 2 diabetes cirrhosis therapeutic focus competitive edge partnerships collaborations health wellness & fitness hospital & health care

SG

Scott Gangloff Chief Technical Officer at Akero Therapeutics

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Kitty Yale in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Akero Therapeutics.

How do I reach Kitty Yale directly?

Kitty Yale's verified email address is available to MessageCEO Pro subscribers. They currently serve as EVP and Chief Development Officer at Akero Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Kitty Yale work for?

Kitty Yale is EVP and Chief Development Officer at Akero Therapeutics, a company in the research sector with 70.0 employees. The company is based in San Francisco, California.

Can I pitch or sell to Kitty Yale?

As EVP and Chief Development Officer at Akero Therapeutics, Kitty Yale is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Kitty Yale directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Kitty Yale in?

Kitty Yale works in the research industry as EVP and Chief Development Officer at Akero Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Kitty Yale's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Kitty Yale's profile is kept up-to-date with the latest available information.

Last updated: May 14, 2026